Intracranial xenograft models further elucidated that BIP-MPC-NP enhanced TMZ chemosensitivity via attenuating the EGFR and MET signaling pathways, including phosphorylation of p38 and reducing E2F1 expression accompanied by elevated TTP in TMZ-resistant gliomas. The gene discussed is E2F1; the disease is glioma.